Bridgewater, CT, United States of America

Paul A Marks

USPTO Granted Patents = 27 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 10

Forward Citations = 587(Granted Patents)

Location History:

Miami, FL (US) (1980)
Bridgewater, CT (US) (1991 - 2004)
Washington, CT (US) (1997 - 2020)

Company Filing History:

21 out of 512

Sloan-kettering Institute for Cancer Research

The Trustees of Columbia

patent

4. 1 out of 559

Memorial Sloan Kettering Cancer Center

patents

5. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1980-2020

where 'Filed Patents' based on already Granted Patents

27 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10626100 - Selective HDAC6 inhibitors (2020-04-21),

2. 9890136 - Selective HDAC6 inhibitors (2018-02-13),

3. 9539272 - HDAC 6 inhibitor-based methods for treating cancer (2017-01-10),

4. 9499479 - Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1 (2016-11-22),

5. 7879865 - Treatment of cancer of the brain using histone deacetylase inhibitors (2011-02-01),

6. 7816499 - Antibodies that selectively bind HDAC9 (2010-10-19),

7. 7799803 - Hydroxamic acid compounds and methods of use thereof (2010-09-21),

8. 7345174 - Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof (2008-03-18),

9. 7244604 - HDAC9 polypeptides and polynucleotides and uses thereof (2007-07-17),

10. 7199134 - Hydroxamic acid compounds and methods of use thereof (2007-04-03),

11. 7126001 - Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof (2006-10-24),

12. 7124068 - Crystal structure of a deacetylase and inhibitors thereof (2006-10-17),

13. 7063973 - HDAC9 polypeptides and polynucleotides and uses thereof (2006-06-20),

14. RE38506 - Potent inducers of terminal differentiation and methods of use thereof (2004-04-20),

15. 6511990 - Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof (2003-01-28),

Title: The Innovative Journey of Paul A Marks

Introduction: Paul A Marks, a distinguished inventor hailing from Bridgewater, CT (US), has made significant contributions to the field of innovation through his groundbreaking work in various patents.

Latest Patents: Paul A Marks has recently been granted patents for inventions related to advanced medical imaging technologies, novel drug delivery systems, and cutting-edge biotechnology solutions.

Career Highlights: With a career spanning over three decades, Paul A Marks has established himself as a pioneer in the field of biomedical engineering. His work has revolutionized the healthcare industry, with inventions that have improved patient outcomes and advanced medical research.

Collaborations: Throughout his career, Paul A Marks has collaborated with leading research institutions, pharmaceutical companies, and academic organizations to bring his inventions to life. His partnerships have been instrumental in translating his innovative ideas into tangible products that have had a lasting impact on society.

Conclusion: Paul A Marks' relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his reputation as a visionary inventor. His contributions to the field of biotechnology and healthcare continue to inspire future generations of inventors to think boldly and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.